Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Op-Eds
PETA or Medical Research? by Steven J. Milloy
People for the Ethical Treatment of Animals launched a campaign last week against a drug testing company for alleged violations of animal welfare laws.<?xml:namespace…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TRANSPORTATION Transportation Secretary Norman Mineta warns Amtrak that federal funds may not be available to bail…
Op-Eds
Infant Formula Ambush by Henry I. Miller
Self-styled public-health activists often pursue issues that are surrogates for their real agenda. One example is the continuing attack on infant formula. Activists'…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. SPAM E-MAIL Spam “zombies”—computers that are hijacked to send out a spammer’s unwanted email messages—get…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TECHNOLOGY A small group of U.S. House members is proposing new federal rules for disposal…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CIVIL LIBERTIES The Senate Select Committee on Intelligence begins debate over whether to renew…